Cargando…
737. Timing, Microbiology, Antibiotic Use, and Financial Impact of Left Ventricular Assist Device Infections: A Prospective Case-Control Approach
BACKGROUND: Left-ventricular assist devices (LVAD) are increasingly used to treat advanced heart failure, and infection is a leading complication. Although the main registries such as INTERMACS publish annual quality reports, recently they have called for more details regarding antibiotic exposure a...
Autores principales: | Ficinski, Matthew, Glassman, Shannon, Wojciechowski, Katrina J, West, Jennifer, Feitell, Scott, Lesho, Emil P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677564/ http://dx.doi.org/10.1093/ofid/ofad500.798 |
Ejemplares similares
-
The Impact of Narrowing Perioperative Antibiotic Prophylaxis for Left-Ventricular-Assist Device Implantation
por: Allen, Lauren, et al.
Publicado: (2021) -
Echocardiography in Left Ventricular Assist Device
por: Helmy, Sherif M., et al.
Publicado: (2010) -
No Association between Clinical Periodontal Conditions and Microbiological Findings on Driveline of Patients with Left-Ventricular Assist Devices (LVAD)
por: Schmalz, Gerhard, et al.
Publicado: (2021) -
Choosing Between Left Ventricular Assist Devices and Biventricular Assist Devices
por: Shehab, Sajad, et al.
Publicado: (2019) -
Epidemiology and Microbiology of First Ventricular Assist Device Infection and Their Effect on Outcomes
por: Guzman, Merilda Blanco, et al.
Publicado: (2017)